Institute for Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Germany.
Department of Radiology, Neuroradiology and Nuclear Medicine, Ruhr-University Bochum, Germany.
Neuroradiol J. 2022 Jun;35(3):319-328. doi: 10.1177/19714009211042877. Epub 2021 Sep 3.
Data on outcome after endovascular treatment of basilar artery fenestration aneurysms (BAFAs) is limited. This study presents our multi-centre experience of BAFAs treated by different reconstructive techniques including coils, stent-assisted coiling (SAC), flow diversion and intra-saccular flow disruption with the Woven Endobridge (WEB).
Retrospective analysis of 38 BAFAs treated endovascularly between 2003 and 2020. The primary endpoint was complete aneurysm obliteration defined as Raymond-Roy occlusion classification (RROC) I on immediate and follow-up (FU) angiography. The secondary endpoints were procedure-related complications, rate of re-treatment, and clinical outcome.
Endovascular treatment was feasible in 36/38 aneurysms (95%). The most frequent strategy was coiling (21/36, 58%), followed by SAC (7/36, 19%), WEB embolization (6/36, 17%) and flow diversion (2/36, 6%). A successful aneurysm occlusion (defined as RROC 1 and 2) on the final angiogram was achieved in 30/36 (83%) aneurysms including all patients presenting with baseline subarachnoid haemorrhage and 25/36 (69%) were occluded completely. Complete occlusion (RROC 1) was more frequently achieved in ruptured BAFAs (15/25, 60% v. 2/11, 18%; = 0.031). Procedure-related complications occurred in 3/36 (8%) aneurysms. Re-treatment was executed in 12/36 (33%) aneurysms. After a median angiography FU of 38 months, 30/31 (97%) BAFAs were occluded successfully and 25/31 (81%) showed complete occlusion.
Reconstructive endovascular treatment of BAFAs is technically feasible with a good safety profile. Although in some cases re-treatment was necessary, a high rate of final aneurysm occlusion was achieved.
关于血管内治疗基底动脉开窗动脉瘤(BAFA)的结果数据有限。本研究介绍了我们多中心的经验,涉及通过不同的重建技术治疗 BAFAs,包括线圈、支架辅助线圈(SAC)、血流分流和使用 Woven Endobridge(WEB)进行腔内血流中断。
回顾性分析了 2003 年至 2020 年间血管内治疗的 38 个 BAFAs。主要终点是即刻和随访(FU)血管造影上完全动脉瘤闭塞,定义为 Raymond-Roy 闭塞分类(RROC)I 级。次要终点是与治疗相关的并发症、再治疗率和临床结果。
38 个动脉瘤中的 36 个(95%)可进行血管内治疗。最常见的策略是线圈填塞(21/36,58%),其次是 SAC(7/36,19%)、WEB 栓塞(6/36,17%)和血流分流(2/36,6%)。30/36 个(83%)动脉瘤的最终血管造影上实现了成功的动脉瘤闭塞(定义为 RROC 1 和 2),包括所有基线蛛网膜下腔出血的患者和 25/36(69%)完全闭塞。破裂的 BAFAs 更常达到完全闭塞(RROC 1)(15/25,60%比 11/25,18%;=0.031)。36 个动脉瘤中有 3 个(8%)发生与治疗相关的并发症。12/36 个(33%)动脉瘤进行了再治疗。中位血管造影随访 38 个月后,30/31(97%)个 BAFAs成功闭塞,25/31(81%)个完全闭塞。
BAFAs 的血管内重建治疗在技术上是可行的,具有良好的安全性。尽管在某些情况下需要再次治疗,但最终达到了很高的动脉瘤闭塞率。